Pharma can target ultra-rare conditions — the next step is financing them

​
Watch Now
Date:
July 26, 2023

As science has enabled care for previously untreatable, ultra-rare conditions, health systems and governments are struggling with ways of financing research and development of these therapies. What are the solutions when the science has progressed, but the economics haven't?

Click here to find additional information and registration details.

Topics

Health Economics & Outcomes Research (HEOR)

Watch Now

​
Watch On Demand

Related Content

​
On Demand
September 29, 2025

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Sponsor:
The PPD clinical research business of Thermo Fisher Scientific Inc.
Panalgo, LLC
See more
​
On Demand
July 8, 2025

Network meta-analysis and its role in evidence-based decision-making

Sponsor:
ICON
See more
​
Upcoming
June 7, 2026

Network meta-analysis and its role in evidence-based decision-making

Sponsor:
ICON
​
Upcoming
June 7, 2026

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Sponsor:
HealthLumen
ICON
​
Upcoming
June 7, 2026

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

Sponsor:
ICON
​
Upcoming
June 7, 2026

RWE reality check: Routine patient health records and regulatory requirements

Sponsor:
Cardinal Health
​
Upcoming
June 7, 2026

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Sponsor:
ICON
​
Upcoming
June 7, 2026

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Sponsor:
ICON
​
Upcoming
June 7, 2026

Market Access - Transforming BioTech Commercial Decisions?

​
Upcoming
June 7, 2026

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Sponsor:
Panalgo, LLC
​
Upcoming
June 7, 2026

Insights from the 2024 Salary Survey Report by HealthEconomics.com

​
Upcoming
June 7, 2026

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Sponsor:
OPEN Health
​
Upcoming
June 7, 2026

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Sponsor:
Carelon Research
​
Upcoming
June 7, 2026

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Sponsor:
ICON
​
Upcoming
June 7, 2026

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Sponsor:
ICON
​
Upcoming
June 7, 2026

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting
​
Upcoming
June 7, 2026

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Sponsor:
OPEN Health
​
Upcoming
June 7, 2026

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Sponsor:
Inspire
​
Upcoming
June 7, 2026

Pharma can target ultra-rare conditions — the next step is financing them

​
Upcoming
June 7, 2026

Advancing identity data management for digital engagement: How leading organizations are doing it

​
Upcoming
June 7, 2026

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

​
Upcoming
June 7, 2026

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

​
Upcoming
June 7, 2026

Closing the gaps of getting data to make decisions

​
Upcoming
June 7, 2026

The role of patient-centric technologies & tokenization in RWE studies

​
Upcoming
June 7, 2026

How Digital Health Can Empower Cancer Patients

​
Upcoming
June 7, 2026

Clinical Trial Innovation: How Healthcare Technology is Evolving

​
Upcoming
June 7, 2026

Connected communities: Advancing population health through data and emerging technology

​
Upcoming
June 7, 2026

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

​
Upcoming
June 7, 2026

The reimagined hospital: How health systems are keeping up with new tech

​
Upcoming
June 7, 2026

L7|LIVE SF - Tuesday, June 13th, 2023

​
Upcoming
June 7, 2026

Transforming Healthcare Using Big Data and Remote Monitoring

​
Upcoming
June 7, 2026

Synthesise RWE and AI. Transform patient-driven healthcare

​
Upcoming
June 7, 2026

Endpoints at #DIA23

​
Upcoming
June 7, 2026

From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer

​
Upcoming
June 7, 2026

Ushering in the new era of payvider integration

​
Upcoming
June 7, 2026

Partnering with NHS in a crisis: The role for industry

​
Upcoming
June 7, 2026

Unlock the Power of Data Review & Collaboration: Maximizing Trial Success

​
Upcoming
June 7, 2026

HTA Implementation in the MEA Region - an Overview from WHO and Country Updates

​
Upcoming
June 7, 2026

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

​
Upcoming
June 7, 2026

How to Supercharge Real World Evidence Generation in Phase IV Trials

​
Upcoming
June 7, 2026

HEOR Writing: The Ins and Outs of Value Communications

​
Upcoming
June 7, 2026

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

​
Upcoming
June 7, 2026

FDA Patient-Focused Drug Development (PFDD) Guidance

​
Upcoming
June 7, 2026

Creating Digital Biomarkers with Real-World and Existing Data by Xtalks

​
Upcoming
June 7, 2026

Beyond the payment variance report: How to resolve common, costly underpayment issues

​
Upcoming
June 7, 2026

Webcast: Strategies to Simplify Insurance Discovery

​
Upcoming
June 7, 2026

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

​
Upcoming
June 7, 2026

Measuring the intangible- what is the true value of a "patient centric" initiative

​
Upcoming
June 7, 2026

Champion a seamless end-to-end insight generation process

​
Upcoming
June 7, 2026

Different HTA Perspectives on Reliably Estimating Treatment Effects

​
Upcoming
June 7, 2026

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

​
Upcoming
June 7, 2026

Fit for Local Context? Establishing or Improving Deliberative Processes for HTA

​
Upcoming
June 7, 2026

Evidence Matters 2022

​
Upcoming
June 7, 2026

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

​
Upcoming
June 7, 2026

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

​
Upcoming
June 7, 2026

Cell & Gene Day 2022 | Virtual Event | August 24th

​
Upcoming
June 7, 2026

Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT

​
Upcoming
June 7, 2026

Confronting care inequities in hospital medicine - August 18th, 2022

​
Upcoming
June 7, 2026

Pain R&D: Plenty of pain to go around, but who's making gains?

​
Upcoming
June 7, 2026

AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th

​
Upcoming
June 7, 2026

Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making

​
Upcoming
June 7, 2026

Selecting Rapid Review Methods for Health Technology Assessment

​
Upcoming
June 7, 2026

Predicting Payer Uptake with Precision

​
Upcoming
June 7, 2026

It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability

​
Upcoming
June 7, 2026

Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality

​
Upcoming
June 7, 2026

Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews

​
Upcoming
June 7, 2026

Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy

​
Upcoming
June 7, 2026

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

​
Upcoming
June 7, 2026

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Sponsor:
Evidera, part of PPD
​
Upcoming
June 7, 2026

Minimizing the Impact of Cross-Cultural Differences in COA Translations

Sponsor:
ICON
​
Upcoming
June 7, 2026

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Sponsor:
PHAR
​
Upcoming
June 7, 2026

Medicare Part D: Price Negotiation Panel Discussion

Sponsor:
ICON
​
Upcoming
June 7, 2026

Finding Value in Linking Real-World Data with Social Determinants of Health

Sponsor:
Magnolia Market Access
​
Upcoming
June 7, 2026

Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Sponsor:
Alira Health
​
Upcoming
June 7, 2026

Streamlining Health Technology Assessments by Automating Literature Reviews

Sponsor:
DistillerSR
​
Upcoming
June 7, 2026

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

Sponsor:
Genesis Research Group
​
Upcoming
June 7, 2026

Achieving Consensus When Everyone is an Expert, but No One Agrees

Sponsor:
PHAR
​
Upcoming
June 7, 2026

Making HEOR More Accessible to Patients

Sponsor:
OPEN Health
​
Upcoming
June 7, 2026

An Introduction to Infectious Disease Modeling

Sponsor:
ICON
​
Upcoming
June 7, 2026

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

Sponsor:
ICON
​
Upcoming
June 7, 2026

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

Sponsor:
Syneos Health
​
Upcoming
June 7, 2026

Understanding Health Care Decision Maker Preferences for Optimized Engagement

Sponsor:
ICON
​
Upcoming
June 7, 2026

Data Integrity in Decentralized Clinical Trials (DCTs)

Sponsor:
Actu-Real
​
Upcoming
June 7, 2026

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

Sponsor:
Cerner Enviza
​
Upcoming
June 7, 2026

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

Sponsor:
HealthCore, Inc.
​
Upcoming
June 7, 2026

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

Sponsor:
DistillerSR
​
Upcoming
June 7, 2026

Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible

Sponsor:
ICON
​
Upcoming
June 7, 2026

Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

Sponsor:
PHAR
​
Upcoming
June 7, 2026

Value-Based Agreements - Are We Going to See More or Less of Them?

Sponsor:
Actu-Real
​
Upcoming
June 7, 2026

Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved Monitoring & Supportive Care

Sponsor:
Kent Scientific Corporation
​
Upcoming
June 7, 2026

Pulse Wave Velocity: Theory, Applications, Methods, and Future Directions

Sponsor:
ADInstruments
​
Upcoming
June 4, 2026

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Sponsor:
The PPD clinical research business of Thermo Fisher Scientific Inc.
Panalgo, LLC

Related Content

​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo